𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy

✍ Scribed by Kim, Nan Hee; Oh, Jeong Heon; Seo, Ji A.; Lee, Kye Won; Kim, Sin Gon; Choi, Kyung Mook; Baik, Sei Hyun; Choi, Dong Seop; Kang, Young Sun; Han, Sang Youb; Han, Kum Hyun; Ji, Yi Hwa; Cha, Dae Ryong


Book ID
109066954
Publisher
Nature Publishing Group
Year
2005
Tongue
English
Weight
185 KB
Volume
67
Category
Article
ISSN
0085-2538

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Significance of vascular endothelial gro
✍ Masakazu Toi; Hiroko Bando; Taeko Ogawa; Mariko Muta; Carsten Hornig; Herbert A. πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 116 KB

## Abstract Angiogenesis, the formation of new blood vessels, is controlled by a balance between positive and negative endothelial regulatory factors. Soluble vascular endothelial growth factor receptor‐1 (sVEGFR1), a naturally occurring soluble form of VEGFR1, is a negative counterpart of the vasc

Expression of vascular endothelial growt
✍ Langer, Ingrid; Vertongen, Pascale; Perret, Jason; Fontaine, Jeanine; Atassi, Gh πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 406 KB πŸ‘ 1 views

Background. Vascular endothelial growth factor (VEGF) is a specific endothelial cell mitogen that stimulates angiogenesis and plays a crucial role in tumor growth. The aim of the present study was to evaluate the expression of VEGF and of its two high-affinity tyrosine kinase receptors (KDR and Flt-